908-359-8980 Menu

Improving the health of our patients through groundbreaking clinical research

The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.

Current Clinical Trials:

Study: Injectable Treatment to Treat Cutaneous Squamous Cell Carcinoma

Purpose: The purpose of this trial is to evaluate the safety, tolerability, and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma in situskin cancer(isSCC).

Qualifications:

  • Male and Females, 18 years or older
  • Current diagnosis of SCC

Duration: Up to 14 weeks

Location: Hackensack, NJ

Compensation: Up to $785

Interested in participating in our clinical research study? Please click here.


Study: Injectable Treatment to Treat Keloids

Purpose: To assess the safety, tolerability, and efficacy of various doses of STP705 (10μg, 20μg, 30μg and 40μg) intradermal injection and placebo, when injected into the keloid excision site, to prevent the recurrence of keloids following their excision. The study treatments are administered once per week. There will be four (4) follow-up visits at one (1), three (3), six (6) and nine (9) months after your keloid surgery.

Qualifications:

  • Male and Females, 18 – 60 years old
  • Have at least one keloid scar present for at least one year on the upper body, arms, or legs

Duration: 54 weeks

Location: Hackensack, NJ

Compensation: Up to $1,100 if all study visits are completed

To participate Please click here.


Study: Atopic dermatitis

Purpose: A clinical research study to test the effectiveness of an investigational medication to reduce symptoms. This study will also include 2 vaccines commonly used in adults with moderate-to-severe AD. The main purpose of this study is to learn whether an investigational drug could impact how effective certain vaccines may be and how effective and safe the study drug is in patients with moderate-to-severe AD.

Qualifications:

  • Male and Females, ages 18 to 55 years of age
  • Have moderate to severe atopic dermatitis for at least 1 year
  • Failure to improve with topical prescriptions

Duration: 26 weeks/ visiting doctors office 10 to 12 times

Location: Hackensack, NJ

Compensation: If all visits are kept, up to $375 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Evaluation of the Mind.Px Patch on Response to Biologic Treatment for Patients with Plaque Psoriasis

Purpose: The purpose of this study is to evaluate the impact of Mind.Px on response to biologic treatment for patients suffering from plaque psoriasis, as judged by the mean change in the Psoriasis Area Severity index (PASI) score from baseline to end of Week 16 of the study.

Qualifications:

  • Male and Females, 18 years or older
  • Current diagnosis of Plaque Psoriasis

Duration: Up to 20 weeks

Location: Hackensack, NJ

Compensation: Up to $630 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement

Purpose: To evaluate the clinical efficacy of SofWave treatment to improve acne scars appearance. Eligible patients will receive 3 treatments (4-6 weeks apart) on the facial acne scars using Sofwave System. All patients will return to the clinic for one follow up visit at 3 months post last treatment.

Qualifications:

  • Female and male subjects, ages 22 to 80 years
  • Mild to moderate facial acne scars

Duration: Approx. 6 months

Location: Hackensack, NJ

Compensation: Up to $120 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

Interested in participating in our clinical research study? Please click here.

What to expect during a clinical trial:

  • Access to new investigational treatments before they are made widely available
  • Financial compensation for participation
  • An opportunity to contribute to the advancement of medical science through research
  • Study visits conducted by a trained and dedicated research team
  • Adherence to strict industry and safety standards.
  • Evaluations performed by one of our certified provide

To learn more contact: Diana Aranzazu, [email protected], 609-219-5621

Schedule A Consultation

Contact Us

Skin Laser & Surgery Specials of NY & NJ is now a division of Schweiger Dermatology Group.

Practice Policy Update Regarding COVID-19

The health and safety of our patients and staff is our top priority. Our in-office safety policies are aligned with the latest guidelines issued by the CDC and local government officials related to COVID-19.

New safety policies for patients:

  • Patients will undergo screening questions and receive comprehensive instructions about our new policies prior to their appointment.
  • To minimize contact, we will offer patients virtual check in and check out.
  • Patients will be instructed to come to the office wearing a mask.
  • Patient temperatures will be checked via forehead scanners upon arrival to the office.
  • We have reorganized our offices to maximize social distancing and cleanliness, and we have altered workflows to allow patients to wait outside or in their cars until their exam room is ready. Patients will be contacted via text message or phone call when the provider is ready for the visit to begin.
  • We are asking for patients to arrive at their appointment alone. For children and adult patients who require a caretaker, one adult may accompany the patient.
  • Patients who are sick or have had exposures to COVID-19 will be rescheduled.
  • Offices will be cleaned and disinfected frequently throughout the day.
  • Teledermatology appointments remain available for patients who prefer to be seen virtually.

New safety policies for office & staff:

  • All of our staff have completed training on all new workflows and infection prevention measures.
  • All of our clinical staff will be wearing appropriate personal protective equipment (PPE) during patient encounters to include masks and eye protection.
  • Our exam rooms are sanitized before and after every patient visit.
  • All SLSS team members will be screened for symptoms and/or fever daily prior to coming to work.
BOOK NOW
Contact Us